Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated November 11, 2022, the Company and its auditors are continuing to work diligen...

Related Keywords

Burlington ,Newfoundland ,Canada ,Canadian ,Mark Upsdell ,Company Consolidated Craft Brands ,Ontario Securities Commission ,Rapid Dose Therapeutics Corp ,Canadian Securities Exchange ,Rapid Dose Therapeutics ,Canadian Securities ,Consolidated Craft Brands ,Annual Filings ,Chief Executive Officer ,Chief Financial Officer ,Required Documents ,Delayed Filing Announcement ,Dose Therapeutics ,